MELAS- and Kearns-Sayre-type commutation with myopathy and autoimmune polyendocrinopathy

Kinji Ohno, Masahiko Yamamoto, Andrew G. Engel, C. Michel Harper, Lewis R. Roberts, Gerry H. Tan, Vahab Fatourechi

Research output: Contribution to journalArticlepeer-review

44 Scopus citations


A 35-year-old woman with features of Kearns-Sayre syndrome consisting of progressive ptosis, ophthalmoparesis, mitochondrial myopathy, and pigmentary retinopathy also had autoimmune polyglandular syndrome type II (Addison's disease, autoimmune insulin-dependent diabetes mellitus, Hashimoto's thyroiditis, and primary ovarian failure). There was no history of similarly affected relatives. Analysis of muscle mitochondrial DNA (mtDNA) revealed a 2,532-bp deletion of the type seen in Kearns-Sayre syndrome as well as a heteroplasmic A3243G mutation in the tRNA-Leu(UUR) gene of the type seen in mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS). The patient's blood and her mother's blood harbored the A3243G mutation but not the deletion, and the maternal grandmother's blood had neither mutation. In muscle, the species of mtDNA harboring the deletion was exclusively associated with the species harboring the A3243G mutation, suggesting that the point mutation predisposed to the large-scale deletion. The mtDNA species with both mutations accounted for 88% of total muscle mtDNA. Other and as yet unrecognized point mutations in mtDNA might also be associated with, and possible causally related to, large-scale mtDNA deletions.

Original languageEnglish (US)
Pages (from-to)761-766
Number of pages6
JournalAnnals of neurology
Issue number6
StatePublished - Jun 1996

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology


Dive into the research topics of 'MELAS- and Kearns-Sayre-type commutation with myopathy and autoimmune polyendocrinopathy'. Together they form a unique fingerprint.

Cite this